Internet-based Group Contingency Management to Promote Smoking Abstinence
This study is ongoing, but not recruiting participants.
Sponsor:
National Development and Research Institutes, Inc.
Collaborator:
Information provided by (Responsible Party):
Jesse Dallery, National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier:
NCT01181661
First received: August 12, 2010
Last updated: April 30, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to develop and test an Internet-based group contingency management program designed to promote smoking cessation.
| Condition | Intervention |
|---|---|
|
Cigarette Smoking |
Behavioral: Full Group Contingency Behavioral: Mixed Group Contingency |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Caregiver) Primary Purpose: Treatment |
| Official Title: | Internet-based Group Contingency Management to Promote Smoking Abstinence |
Resource links provided by NLM:
Further study details as provided by National Development and Research Institutes, Inc.:
Primary Outcome Measures:
- Breath CO [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]Twice daily breath CO samples obtained during baseline and treatment
Secondary Outcome Measures:
- Point prevalence measure of abstinence [ Time Frame: at the end of treatment (approximately week 4) and at 3 month follow-up ] [ Designated as safety issue: No ]Abstinence will be defined as: (a) CO sample ≤ 4 ppm; (b) cotinine < 50 ng/ml; and (c) reporting not smoking, not even a puff in the last 7 days.
- Duration of abstinence during treatment. [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]The longest duration of sustained abstinence (CO ≤ 4 ppm) based on the twice-daily breath samples during the treatment period.
- Rate of social exchanges [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]The number of comments posted on the discussion forum during treatment.
| Estimated Enrollment: | 40 |
| Study Start Date: | August 2010 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Full Group Contingency
This group (n = 20) will earn vouchers based only on team (n = 4) performance. Only if all members of the team submit a negative sample (CO ≤ 4 ppm), will they each earn a voucher.
|
Behavioral: Full Group Contingency
This group (n = 20) will earn vouchers based only on team (n = 4) performance. Only if all members of the team submit a negative sample (CO ≤ 4 ppm), will they each earn a voucher.
|
|
Experimental: Mixed Group Contingency
This group (n = 20) will earn vouchers based on both individual and team (n = 4) performance. If an individual submits a negative sample (CO ≤ 4 ppm), s/he will earn a voucher. Additionally, bonus vouchers will be earned if all team members submit negative samples.
|
Behavioral: Mixed Group Contingency
This group (n = 20) will earn vouchers based on both individual and team (n = 4) performance. If an individual submits a negative sample (CO ≤ 4 ppm), s/he will earn a voucher. Additionally, bonus vouchers will be earned if all team members submit negative samples.
|
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- self-reported smoker
- ability to use the Internet
- permission to contact applicant by phone
Exclusion Criteria:
- self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study
- inability to avoid high levels of ambient CO (e.g., occupational exposure; lives with a another smoker who smokes in the home)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01181661
Locations
| United States, Florida | |
| University of Florida | |
| Gainesville, Florida, United States, 32611 | |
| United States, New York | |
| National Development and Research Institutes | |
| New York City, New York, United States, 10010 | |
Sponsors and Collaborators
National Development and Research Institutes, Inc.
Investigators
| Principal Investigator: | Jesse Dallery, PhD | National Development and Research Institutes, Inc. |
More Information
No publications provided
| Responsible Party: | Jesse Dallery, Principal Investigator, National Development and Research Institutes, Inc. |
| ClinicalTrials.gov Identifier: | NCT01181661 History of Changes |
| Other Study ID Numbers: | 1R21DA029162, 1R21DA029162 |
| Study First Received: | August 12, 2010 |
| Last Updated: | April 30, 2013 |
| Health Authority: | United States: Federal Government United States: Institutional Review Board |
Keywords provided by National Development and Research Institutes, Inc.:
|
Cigarette Smoking Nicotine Contingency Management Voucher Reinforcement |
Smoking Abstinence Internet Internet-based Treatment Group Contingencies |
Additional relevant MeSH terms:
|
Smoking Habits |
ClinicalTrials.gov processed this record on May 23, 2013